Table 3.
Morbidity of severe COVID-19 patients. DVT, deep vein thrombosis. PE, pulmonary embolism, VTE, venous thromboembolism, NIV, non-invasive ventilation, ECMO, extracorporeal membrane oxygenation, AKI, acute kidney injury, LOS, length of stay, ICU, intensive care unit. The difference between the groups were not significant. Normal FXIII activity was defined as activity level >79 %. Low FXIII levels were levels were defined as activity level <79 %
| FXIII activity | Overall (N=34) |
Normal (>79 %) (N=9) |
Low (<79 %) (N=25) |
|---|---|---|---|
| DVT | 5 (15 %) | 2 (22 %) | 3 (12 %) |
| PE | 4 (12 %) | 3 (33 %) | 1 (4 %) |
| Time from diagnosis to VTE (days) | 14.5 (4-23) | 17 (4-23) | 13 (11-17) |
| Time from admission to VTE (days) | 11 (0-24) | 16 (12-24) | 7 (0-13) |
| Major Bleed | 8 (23.5 %) | 0 | 8 (32 %) |
| NIV | 23 (68 %) | 8 (89 %) | 15 (60 %) |
| ECMO | 6 (18 %) | 2 (22 %) | 4 (16 %) |
| Medical Hemodynamic support | 24 (71 %) | 6 (67 %) | 18 (72 %) |
| AKI | 14 (41 %) | 2 (22 %) | 12 (48 %) |
| Mortality during follow up period | 13 (38 %) | 3 (33 %) | 10 (40 %) |
| Follow up duration (days) | 18 (5-45) | 13 (5-35) | 18 (8-45) |
| LOS ICU (days) | 25 (9-45) | 35.5 (35-36) | 18 (9-45) |